Allarity Therapeutics, Inc. Other Selling, General and Administrative Expense
Allarity Therapeutics, Inc. (ALLR) reported Other Selling, General and Administrative Expense of $21.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2024-05-14
- Allarity Therapeutics, Inc. other selling, general and administrative expense for the quarter ending 2024-03-31 was $21.00K, a 74.39% decline year-over-year.
- Allarity Therapeutics, Inc. other selling, general and administrative expense for the quarter ending 2023-03-31 was $82.00K.
- Allarity Therapeutics, Inc. other selling, general and administrative expense for fiscal 2023 was $47.00K, a 95.93% decline from fiscal 2022.
- Allarity Therapeutics, Inc. other selling, general and administrative expense for fiscal 2022 was $1.16M.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|
| 2024-03-31 | $21.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $47.00K 10-K · filed 2024-03-08 | |
| 2023-03-31 | $82.00K 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $1.16M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |